A convolutional neural network trained and internally validated on more than 15,000 lung CT scans has correctly reclassified indeterminate pulmonary nodules into low-risk or high-risk categories.

The FDA has permitted the use of Aidoc’s AI models for the detection and prioritization of incidental CT findings associated with COVID-19.

AI developers working to refine COVID-19 detection in chest x-rays must navigate two unavoidable speed bumps.

Researchers are hard at work developing new AI algorithms that could help radiologists diagnose COVID-19 patients.

An AI algorithm has slightly outperformed neurologists at identifying or ruling out Alzheimer’s disease from MRI brain scans combined with demographic information and neuropsychological test results.

Scale AI is funding eight research projects focused on helping Canada respond to the ongoing COVID-19 pandemic, an investment that adds up to $3.4 million.

The test may also have a second important use—improving the treatment of COVID-19 patients.

The FDA has cleared an investor-backed teleradiology provider to market two AI algorithms the company developed to flag certain stroke-associated findings in images from head CT scans.